Table 3.

Comparison between the study groups in the upper GIT symptoms

		Omentopexy group (n = 45)	Non-omentopexy group (n = 46)	p
		n (%)	n (%)
1-month symptoms	No symptoms	42(93.4)	34 (73.9)	0.037X*
	Less than 3	2 (4.4)	5 (10.9)
	3 or more	1(2.2)	7 (15.2)
	Nausea	2 (4.4)	7 (15.2)	0.085Z
	Vomiting	1 (2.2)	2 (4.3)	1 (2.2)
	Fluid intolerance	0 (0)	5 (10.9)	0.023Z*
	Heart burn	1 (2.2)	6 (13)	0.053Z
	Dyspepsia	1 (2.2)	2 (4.3)	0.57Z
	Dysphagia	1 (2.2)	1 (2.2)	0.99Z
	Regurgitation	1 (2.2)	6 (13)	0.053Z
	Chest pain	0 (0)	4 (8.7)	0.043Z*
3-month symptoms	No symptoms	42 (93.3)	41 (89.1)	0.34X
	Less than 3	2 (4.4)	1 (2.2)
	3 or more	1 (2.2)	4 (8.7)
	Nausea	1 (2.2)	2 (4.3)	0.57Z
	Vomiting	0 (0)	0 (0)	–
	Fluid intolerance	0 (0)	0 (0)	–
	Heart burn	2 (4.4)	4 (8.7)	0.41Z
	Dyspepsia	1 (2.2)	1 (2.2)	0.99Z
	Dysphagia	1 (2.2)	1 (2.2)	0.99Z
	Regurgitation	1 (2.4)	4 (8.7)	0.18Z
	Chest pain	0 (0)	2 (4.3)	0.16Z

^*Statistically significant

^UMann-Whitney test

^XChi-square test

^ZZ score for proportion